Your browser doesn't support javascript.
loading
Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy.
Mayhew, Anna G; Moat, Dionne; McDermott, Michael P; Eagle, Michelle; Griggs, Robert C; King, Wendy M; James, Meredith K; Muni-Lofra, Robert; Shillington, Alison; Gregson, Sarah; Pallant, Lindsey; Skura, Christy; Staudt, Loretta A; Eichinger, Katy; McMurchie, Heather; Rabb, Rosanna; Di Marco, Marina; Brown, Sarah; Zanin, Riccardo; Arnoldi, Maria Teresa; McIntyre, Melissa; Wilson, Amelia; Alfano, Lindsay N; Lowes, Linda P; Blomgren, Colleen; Milev, Evelin; Iodice, Mario; Pasternak, Amy; Chiu, Angela; Lehnert, Ilka; Claus, Nicole; Dieruf, Kathy A; Rolle, Enrica; Nicorici, Alina; Andres, Barbara; Hobbiebrunken, Elke; Roetmann, Gerda; Kern, Victoria; Civitello, Matthew; Vogt, Sibylle; Hayes, Melissa J; Scholtes, Cheryl; Lacroix, Catherine; Gunn, Tara; Warner, Sinead; Newman, Jennifer; Barp, Andrea; Kundrat, Katherine; Kovelman, Staci; Powers, Penny J.
Afiliación
  • Mayhew AG; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle Upon Tyne, NE1 3BZ, United Kingdom. Electronic address: anna.mayhew@ncl.ac.uk.
  • Moat D; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
  • McDermott MP; Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States; Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, United States.
  • Eagle M; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle Upon Tyne, NE1 3BZ, United Kingdom; ATOM International Limited, Gateshead, United Kingdom.
  • Griggs RC; Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States.
  • King WM; Department of Neurology, Neuromuscular Disease Center, The Ohio State University, OH, United States. Electronic address: wking8@columbus.rr.com.
  • James MK; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
  • Muni-Lofra R; John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University, International Centre for Life, Central Parkway, Newcastle Upon Tyne, NE1 3BZ, United Kingdom.
  • Shillington A; Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.
  • Gregson S; Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom.
  • Pallant L; Leeds General Infirmary, Leeds Children's Hospital, United Kingdom.
  • Skura C; Neurology Department, David Geffen School of Medicine at UCLA, Los Angeles, California, United States.
  • Staudt LA; Neurology Department, David Geffen School of Medicine at UCLA, Los Angeles, California, United States.
  • Eichinger K; Department of Neurology, University of Rochester Medical Center, Rochester, NY, United States.
  • McMurchie H; Heartlands Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.
  • Rabb R; Heartlands Hospital, University Hospitals Birmingham, Birmingham, United Kingdom.
  • Di Marco M; Royal Hospital for Children, Glasgow, United Kingdom.
  • Brown S; Royal Hospital for Children, Glasgow, United Kingdom.
  • Zanin R; IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • Arnoldi MT; IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
  • McIntyre M; Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States.
  • Wilson A; Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, United States.
  • Alfano LN; The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States; Department of Pediatrics, The Ohio State University, Columbus, OH, United States.
  • Lowes LP; The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, United States; Department of Pediatrics, The Ohio State University, Columbus, OH, United States.
  • Blomgren C; Department of Rehabilitation Services, Ann and Robert H Lurie Children's Hospital of Chicago, IL, United States.
  • Milev E; Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Iodice M; Dubowitz Neuromuscular Centre, UCL Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Pasternak A; Department of Physical and Occupational Therapy Services, Boston Children's Hospital, Boston, MA, United States.
  • Chiu A; Neuroscience Program, Alberta Children's Hospital, Calgary, Canada.
  • Lehnert I; Department of Neuropediatrics, Medical Faculty Carl Gustav Carus, Technical University Dresden, Germany.
  • Claus N; Department of Neuropediatrics, Medical Faculty Carl Gustav Carus, Technical University Dresden, Germany.
  • Dieruf KA; University of New Mexico, Albuquerque, NM, United States.
  • Rolle E; Neuromuscular Unit, Department of Neurosciences, University of Torino, Italy.
  • Nicorici A; Neuromuscular Research Lab in the Department of PM&R at UC Davis Health, Sacramento, CA, United States.
  • Andres B; University Hospital Essen, Germany.
  • Hobbiebrunken E; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Germany.
  • Roetmann G; Department of Pediatrics and Adolescent Medicine, Division of Pediatric Neurology, University Medical Center Göttingen, Germany.
  • Kern V; Penn State Health Hershey Medical Center, Hershey, PA, United States.
  • Civitello M; Nemours Children's Hospital, Orlando, FL, United States; St Jude Children's Research Hospital, Memphis, TN, United States.
  • Vogt S; Department of Neurosciences, University Children Hospital of Freiburg, Germany.
  • Hayes MJ; Department of Neurology, University of Kansas Medical Center, Kansas, United States.
  • Scholtes C; London Health Science Centre, London ON, Canada.
  • Lacroix C; Children's Hospital of Eastern Ontario Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Gunn T; Royal Manchester Children's Hospital, Manchester, United Kingdom.
  • Warner S; Royal Manchester Children's Hospital, Manchester, United Kingdom.
  • Newman J; UNC Health Care - Rehabilitation Services, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Barp A; Department of Neurosciences, University of Padova, Padua, Italy.
  • Kundrat K; Children's National Hospital, Washington, DC, United States.
  • Kovelman S; Children's National Hospital, Washington, DC, United States.
  • Powers PJ; Vanderbilt University Medical Center, Phi Beta Phi Rehabilitation Institute, Nashville, TN, United States.
Neuromuscul Disord ; 32(6): 460-467, 2022 06.
Article en En | MEDLINE | ID: mdl-35618576
ABSTRACT
The purpose of this study was to quantitate motor performance in 196 genetically confirmed steroid-naïve boys with Duchenne muscular dystrophy (DMD), to evaluate the test-retest reliability of measures of motor performance in young DMD boys, and to assess correlations among the different functional outcomes including timed tests. Boys aged 4-7 years were recruited in the FOR-DMD study, a comparative effectiveness study of different steroid regimens in DMD. Eligible boys had to be able to rise from the floor independently and to perform pulmonary function testing consistently. The boys were evaluated with standardized assessments at the screening and baseline visits at 32 sites in 5 countries (US, UK, Canada, Italy, Germany). Assessments included timed rise from floor, timed 10 m walk/run, six-minute walk distance, North Star Ambulatory Assessment (NSAA) and forced vital capacity (FVC). Mean age at baseline was 5.9 years (range 4.1-8.1 years). Test-retest reliability was high for functional assessments, regardless of time lag between assessments (up to 90 days) and for the majority of age groups. Correlations were strong among the functional measures and timed tests, less so with FVC. Physiotherapy measures are reliable in a young, steroid-naïve population and rise from floor velocity appears to be a sensitive measure of strength in this population.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Distrofia Muscular de Duchenne Límite: Child / Child, preschool / Humans / Male Idioma: En Revista: Neuromuscul Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Distrofia Muscular de Duchenne Límite: Child / Child, preschool / Humans / Male Idioma: En Revista: Neuromuscul Disord Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article